Medical Education Library

Optimizing the clinical identification and management of patients at risk for anaphylaxis

This supplement was sponsored by Dey Pharma, L.P. Medical Exchange International provided editorial support to Dr. Stuart Stoloff.

 

Anaphylaxis is a serious, systemic allergic reaction that is rapid in onset and can cause death. Anaphylaxis often occurs in the absence of a health care professional, so it is essential for patients at risk for anaphylaxis to be identified and prepared in the event of an emergency. Identifying at-risk patients goes beyond a history of anaphylaxis; it is important to identify patients who may be at risk for a more severe anaphylactic reaction. Patients at risk for anaphylaxis should be provided an epinephrine auto-injector and appropriately trained in its use in the community setting.

Recommended Reading

Diabetes Diagnosis Raised Risk of Depression
MDedge Family Medicine
Weekly Exenatide Topped Daily Insulin Glargine : In exenatide patients, 60% had an HbA1c of less than 7%, compared with 48% of glargine patients.
MDedge Family Medicine
Intranasal Insulin Might Improve Mild Cognitive Impairment
MDedge Family Medicine
Tighter BP Control Not Better for Some Diabetics
MDedge Family Medicine
Data Watch: Top 10 Therapeutic Classes by U.S. Sales, 2009
MDedge Family Medicine
Survival Improving in Type 1, but Challenges Remain
MDedge Family Medicine
Thiazolidinediones Tied to Increased Risk of Fracture
MDedge Family Medicine
White Rice Raised Diabetes Risk, Brown Rice Lowered It
MDedge Family Medicine
PCV7 Reduced Penicillin-Nonsusceptible IPD
MDedge Family Medicine
Algorithmic approach to the management of the patient with lumbar spinal stenosis
MDedge Family Medicine